CervoMed Inc. Finite-Lived License Agreements, Gross
CervoMed Inc. (CRVO) had Finite-Lived License Agreements, Gross of $350.50 thousand as of 2011-12-31, per its 10-K/A filed 2013-04-24.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedLicenseAgreementsGross · last filed 2013-04-24
- 2011-12-31: Finite-Lived License Agreements, Gross $350.50K.
| Period end | Finite-Lived License Agreements, Gross |
|---|---|
| 2011-12-31 | $350.50K 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |